Trial reportDrug and alcohol dependence2011
Oral tobacco products: preference and effects among smokers.
Trial report in Drug and alcohol dependence, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Smoking a Dangerous Addiction: A Systematic Review on an Underrated Risk Factor for Oral Diseases.International journal of environmental research and public health · 2021Pooled it
- Systematic Review of Tobacco Use after Lung or Head/Neck Cancer Diagnosis: Results and Recommendations for Future Research.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015Pooled it
- Acute effects of snus in never-tobacco users: a pilot study.The American journal of drug and alcohol abuse · 2018Trial
- A Naturalistic, Randomized Pilot Trial of E-Cigarettes: Uptake, Exposure, and Behavioral Effects.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2017Trial
- Snus undermines quit attempts but not abstinence: a randomised clinical trial among US smokers.Tobacco control · 2017Trial
- A longitudinal, naturalistic study of U.S. smokers' trial and adoption of snus.Addictive behaviors · 2016Trial
- Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.Tobacco control · 2016Trial
- The impact of free trial acceptance on demand for alternative nicotine products: evidence from experimental auctions.Harm reduction journal · 2015Trial
- Public education about the relative harm of tobacco products: an intervention for tobacco control professionals.Tobacco control · 2014Trial
- Brief, instructional smokeless tobacco use among cigarette smokers who do not intend to quit: a pilot randomized clinical trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2014Trial
- Preliminary evaluation of UP2UTeacher, a brief intervention addressing tobacco and nicotine use for high school students.Drug and alcohol dependence · 2026Article
- Psychometric properties of Fagerström Tolerance Questionnaire among Turkmen Nass (Naswar) users.Addiction science & clinical practice · 2023Article
- The acceptability of smokeless tobacco products depends on nicotine levels.Addictive behaviors reports · 2019Article
- Consortium on Methods Evaluating Tobacco: Research Tools to Inform US Food and Drug Administration Regulation of Snus.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2018Review
- Characteristics of "American Snus" and Swedish Snus Products for Sale in Massachusetts, USA.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2018Article
- Using Electrophysiological Measures to Assess the Consumer Acceptability of Smokeless Tobacco Products.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2016Article
- Do Socioeconomic Risk Factors for Cigarette Smoking Extend to Smokeless Tobacco Use?Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2016Article
- Nicotine Absorption from Smokeless Tobacco Modified to Adjust pH.Journal of addiction research & therapy · 2014Article
- Patterns and correlates of polytobacco use in the United States over a decade: NSDUH 2002-2011.Addictive behaviors · 2014Article
- The development and psychometric evaluation of the Smokeless Tobacco Expectancies Scale (STES).Psychological assessment · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundRecently, oral tobacco products have been marketed specifically towards cigarette smokers. These products come in different nicotine doses and formulations (snus vs. lozenge). To date, little research has been conducted to determine how smokers respond to these products. The goal of this study was to examine if smokers prefer certain oral tobacco products based on their specific characteristics.
methodsSmokers interested in quitting underwent a sampling phase and a treatment phase. The sampling phase consisted of testing five different products varying in nicotine dose (high vs. moderate vs. low) and formulation (snus vs. lozenge): General Snus, Camel Snus, Marlboro Snus, Stonewall and Ariva. Each product was sampled in the natural environment on separate days. At the end of the sampling period, subjects chose which product they would use during the 2-week cigarette abstinence phase.
resultsGeneral Snus (high nicotine) was not preferred by any smoker. No significant differences in preferences were observed across the other tobacco products. During the smoking cessation phase, Camel Snus was generally associated with greater craving relief and satisfaction, reduced use of cigarettes, and greater abstinence during follow-up compared to other products.
conclusionThere were no differences in preferences for four of the five oral tobacco products but higher nicotine oral tobacco products were associated with better cessation outcomes among smokers who chose these products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.